These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17392402)

  • 41. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB; Linnet K
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
    Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?
    Potschka H
    Epilepsia; 2010 Aug; 51(8):1333-47. PubMed ID: 20477844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains.
    Lü Y; Yan Y; Wang XF
    Chin Med J (Engl); 2004 Nov; 117(11):1682-6. PubMed ID: 15569486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy.
    Fang Z; Chen S; Qin J; Chen B; Ni G; Chen Z; Zhou J; Li Z; Ning Y; Wu C; Zhou L
    Biomaterials; 2016 Aug; 97():110-21. PubMed ID: 27162079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotoxicity of the anticonvulsant drug phenytoin (PHT): a follow-up study of PHT-untreated epileptic patients. I. Sister chromatid exchange (SCE) analysis.
    Kaul A; Goyle S
    Teratog Carcinog Mutagen; 1999; 19(1):61-72. PubMed ID: 10321411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: insights into the mechanisms of pharmacoresistance.
    Oby E; Caccia S; Vezzani A; Moeddel G; Hallene K; Guiso G; Said T; Bingaman W; Marchi N; Baumgartner C; Pirker S; Czech T; Lo Russo G; Janigro D
    Brain Res; 2006 May; 1086(1):201-13. PubMed ID: 16631625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Sphingosine 1-Phosphate Analogue FTY720 Alleviates Seizure-induced Overexpression of P-Glycoprotein in Rat Hippocampus.
    Gao F; Gao Y; Meng F; Yang C; Fu J; Li Y
    Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):14-20. PubMed ID: 29380527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transport of antiepileptic drugs by P-glycoprotein.
    Zhang C; Kwan P; Zuo Z; Baum L
    Adv Drug Deliv Rev; 2012 Jul; 64(10):930-42. PubMed ID: 22197850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.
    Schaub C; Uebachs M; Beck H
    Epilepsia; 2007 Jul; 48(7):1339-50. PubMed ID: 17441992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of age on P-glycoprotein expression and function in the Fischer-344 rat.
    Warrington JS; Greenblatt DJ; von Moltke LL
    J Pharmacol Exp Ther; 2004 May; 309(2):730-6. PubMed ID: 14757850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of P-glycoprotein overexpression by Ginkgo biloba extract in the brains of pentylenetetrazole-kindled and phenytoin-treated mice.
    Zhang C; Fan Q; Chen SL; Ma H
    Kaohsiung J Med Sci; 2015 Aug; 31(8):398-404. PubMed ID: 26228278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
    Syvänen S; Labots M; Tagawa Y; Eriksson J; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA
    J Nucl Med; 2012 Dec; 53(12):1974-83. PubMed ID: 23143088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibition.
    Scott JA; Wood M; Flood P
    Anesth Analg; 2006 Sep; 103(3):742-6. PubMed ID: 16931690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy.
    Bartmann H; Fuest C; la Fougere C; Xiong G; Just T; Schlichtiger J; Winter P; Böning G; Wängler B; Pekcec A; Soerensen J; Bartenstein P; Cumming P; Potschka H
    Epilepsia; 2010 Sep; 51(9):1780-90. PubMed ID: 20633036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L; Zhao C; Yan M; Zhang LY; Xia YZ
    Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development.
    Virgintino D; Errede M; Girolamo F; Capobianco C; Robertson D; Vimercati A; Serio G; Di Benedetto A; Yonekawa Y; Frei K; Roncali L
    J Neuropathol Exp Neurol; 2008 Jan; 67(1):50-61. PubMed ID: 18091560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.
    Rizzi M; Caccia S; Guiso G; Richichi C; Gorter JA; Aronica E; Aliprandi M; Bagnati R; Fanelli R; D'Incalci M; Samanin R; Vezzani A
    J Neurosci; 2002 Jul; 22(14):5833-9. PubMed ID: 12122045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.